Dudley, Matthew Z.
Omer, Saad B.
O’Leary, Sean T.
Limaye, Rupali J.
Ellingson, Mallory K.
Spina, Christine I.
Brewer, Sarah E.
Bednarczyk, Robert A.
Chamberlain, Allison T.
Malik, Fauzia
Frew, Paula M.
Church-Balin, Cathy
Riley, Laura E.
Ault, Kevin A.
Orenstein, Walter A.
Halsey, Neal A.
Salmon, Daniel A.
Funding for this research was provided by:
National Institute for Allergy and Infectious Diseases (R01AI110482, R01AI110482, R01AI110482, R01AI110482, R01AI110482, R01AI110482, R01AI110482, R01AI110482, R01AI110482, R01AI110482, R01AI110482, R01AI110482, R01AI110482, R01AI110482, R01AI110482, R01AI110482, R01AI110482)
Article History
Received: 23 June 2022
Accepted: 13 October 2022
First Online: 21 November 2022
Declarations
:
: All methods were carried out in accordance with relevant guidelines and regulations. Informed consent was obtained from all participants. The study was approved by the Institutional Review Board (IRB) of Emory University and Sisters of Charity of Leavenworth Health System. Johns Hopkins University and University of Colorado Denver ceded approval to the Emory University IRB.
: Not applicable.
: RJL, SBO, STO, MKE, CIS, SEB, RAB, FM, and CCB declare that they have no competing interests. MZD has received some research support from Merck and Walgreens. ATC received paid consultancy with the American College of Obstetricians and Gynecologists regarding provider-to-patient communications. During this study, PMF had no conflicts or financial disclosures to report; at the time of publication, she is at Merck. WAO is a member of the Scientific Advisory Board for Moderna. KAA is a current member of the federal Advisory Committee on Immunization Practices and is also a member of a similar advisory committee for the American College of Obstetricians and Gynecologists. LER receives consultant fees from GlaxoSmithKline, writer fees from Up to Date and compensation for being on the editorial boards of Contemporary OB/GYN and the New England Journal of Medicine. NAH has received consultant fees from Takeda, Merck and Inovio for service on Data and Safety Monitoring Boards, and from Pfizer and Valneva for service on advisory panels. DAS has received consulting and/or research support form Janssen, Merck, Walgreens, and Pfizer.